Clinical trials experts include:

Utilising advanced statistical methods to enhance clinical trials, speed time to market and reduce costs

16 industry representatives, including 8 directors will join with 4 prominent academics to share their insights on how to:

  • Understand adaptive trials and the best-practice implementation of adaptive methods in your clinical trials design
  • Utilise Bayesian statistics to inform good decision making in the clinical trials process
  • Unravel the problem of missing data and how best to deal with it in the course of your clinical trials
  • Improve your meta analysis using Bayesian statistics and indirect comparison
  • Facilitate dose finding in Phase I using adaptive trial elements
  • Recognise the opportunities and challenges of using biomarkers in the early development stages of clinical trials
  • How to improve the reporting of you safety data using innovative graphical techniques
  • Make use of simulation and modelling as innovative tools to enhance and improve the design and analysis of your clinical trials
  • The future of statistical standardisation: moving towards a global alignment for statistical reporting
  • Appreciate the importance of translational science in optimising your clinical trials processes

Testimonials

What others have to say about Pharma IQ events:

Very good selection of speakers from all relevant areas of expertise.
Novartis Pharma
Great to have a day of practical projects & big pharma. Extremely valuable.
Genentech
Really enjoyed the case examples when a good level of detail was presented. Has been very useful to understand current status as perceived by industry & network with colleagues.
AstraZeneca
Very eye-opening as to what others are doing in this area.
GlaxoSmithKline
Enthusiastic speakers. Several points helped me to develop or validate next steps in deployment plan.
Abbott Ireland
Media Partners
Animated_Media